Nodal Downstaging Versus Primary Tumor Regression as Predictors of Survival After Total Neoadjuvant Therapy for Rectal Cancer: A Retrospective Study

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

NCT00835055 ·Status: WITHDRAWN

Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission

NCT05964530 ·Status: RECRUITING ·Phase: NA

Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma

NCT05563922 ·Status: RECRUITING ·Phase: PHASE2

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

NCT03573791 ·Status: RECRUITING

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

NCT04664504 ·Status: RECRUITING ·Phase: PHASE2

Observation Versus Surgical Resection in Patients With Rectal Cancer Who Achieved Complete Clinical Response After Neoadjuvant Chemoradiotherapy

NCT02052921 ·Status: TERMINATED ·Phase: NA

Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma

NCT00682786 ·Status: COMPLETED ·Phase: PHASE2

Outcomes of Neoadjuvant Therapy for Rectal Cancer in a Tertiary Asian Institute

NCT05607186 ·Status: COMPLETED

AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy

NCT07049627 ·Status: COMPLETED

Register Study of the Neoadjuvanten Treatment by Patients With Rectumcarcinoma

NCT03428867 ·Status: COMPLETED

Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer

NCT01271192 ·Status: UNKNOWN ·Phase: NA

Neoadjuvant Radiotherapy Followed by Transanal Endoscopic Microsurgery for T1-T2 Extraperitoneal Rectal Cancer

NCT02127645 ·Status: COMPLETED ·Phase: PHASE3

Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy

NCT07260526 ·Status: RECRUITING

Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

NCT05274945 ·Status: COMPLETED ·Phase: PHASE2

Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis

NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2

Total Neoadjuvant Therapy in Rectal Cancer

NCT06162650 ·Status: RECRUITING ·Phase: PHASE2

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors

NCT03177382 ·Status: UNKNOWN ·Phase: PHASE3

Oncological Impact of Lateral Nodes in Rectal Cancer

NCT05592873 ·Status: COMPLETED

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment

NCT04915326 ·Status: UNKNOWN

Prognostic Value of PARS Classification for Locally Recurrent Rectal Cancer

NCT06808308 ·Status: COMPLETED

A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer

NCT04852653 ·Status: ACTIVE_NOT_RECRUITING

High Dose Radiotherapy for the Treatment of Rectal Cancer

NCT03541304 ·Status: COMPLETED

Non-operative Management for Locally Advanced Rectal Cancer

NCT03179540 ·Status: RECRUITING ·Phase: NA

A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal Cancer

NCT06746298 ·Status: NOT_YET_RECRUITING